- ►pubget.com [PDF] SE Humphries, D Gable, JA Cooper, H Ireland, … - Journal of Molecular Medicine, 2006 - Springer Page 1. ORIGINAL ARTICLE Common variants in the TCF7L2 gene and predisposition
to type 2 diabetes in UK European Whites, Indian Asians ... Cited by 88 - Related articles - BL Direct - All 8 versions
- ►problemsinanes.com EJ Costello, DL Foley, A Angold - Journal of Amer Academy of Child & Adolescent …, 2006 - journals.lww.com ABSTRACT Objective: To describe the growth of developmental epidemiology in the
past decade and to illustrate it with examples of recent studies. Method: A
review of publications on developmental epidemiology in the past 10 years ... Cited by 65 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org F Lalloyer, B Vandewalle, F Percevault, G … - Diabetes, 2006 - Am Diabetes Assoc Peroxisome proliferator–activated receptor (PPAR) α is a transcription factor
controlling lipid and glucose homeostasis. PPARα-deficient (−/−) mice are
protected from high-fat diet–induced insulin resistance. However, the ... Cited by 34 - Related articles - BL Direct - All 6 versions
JP Wilding - Diabetic Medicine, 2007 - interscience.wiley.com The recent increase in the prevalence of obesity has been associated with a
coincident rise in the prevalence of Type 2 diabetes, whereas weight loss has
been shown to decrease the risk of Type 2 diabetes. The pathophysiological ... Cited by 28 - Related articles - BL Direct - All 4 versions
- ►onlinejacc.org AJ Gilde, JC Fruchart, B Staels - Journal of the American College of Cardiology, 2006 - Elsevier Since their discovery in the early 1990s, the members of the peroxisome
proliferator-activated receptor (PPAR) subfamily of nuclear receptors have been
recognized as therapeutic targets against dyslipidemia and diabetes. Recent ... Cited by 21 - Related articles - BL Direct - All 21 versions
II Ahmetov, IA Mozhayskaya, DM Flavell, IV … - European journal of applied physiology, 2006 - Springer Abstract Peroxisome proliferator-activated receptor a (PPARa) regulates genes
responsible for skeletal and heart muscle fatty acid oxidation. Previous studies
have shown that the PPARa intron 7 G/C polymorphism was associated with ... Cited by 21 - Related articles - BL Direct - All 3 versions
B Gross, B Staels - Best Practice & Research Clinical Endocrinology & …, 2007 - Elsevier Patients with type-2 diabetes mellitus (T2DM) are considered to be at
particularly high risk for cardiovascular disease. Over the last decade, the
members of the peroxisome proliferator-activated receptor (PPAR) subfamily ... Cited by 20 - Related articles - All 15 versions
- ►nih.gov M Miller, J Rhyne, H Chen, V Beach, R Ericson … - Archives of medical research, 2007 - Elsevier Compared to controls, MetS subjects exhibited a greater prevalence of APOC3
promoter polymorphisms. Specifically, the frequency of the variant C-482T and
T-455C alleles was 70.5 and 81.9% of cases compared to 43.4 and 54.1% in ... Cited by 11 - Related articles - All 8 versions
ASF Doney, B Fischer, SP Lee, AD Morris, G … - Nuclear Receptor, 2005 - nuclear-receptor.com Common variants of the PPARA gene have been found to associate with ischaemic
heart disease in non diabetic men. The L162V variant was found to be protective
while the C2528G variant increased risk. L162V has also been associated ... Cited by 11 - Related articles - Cached - All 10 versions
- ►jlr.org T Tanaka, JM Ordovas, J Delgado-Lista, F … - The Journal of Lipid Research, 2007 - ASBMB Peroxisome proliferator-activated receptor (PPAR ) is a ligand-dependent
transcription factor that plays a key role in lipid and glucose homeostasis.
This study evaluated whether variants of PPAR are associated with ... Cited by 9 - Related articles - All 12 versions
